Display options
Cite
Wang QC, Cheng W, Zhang L, et al. Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours. West Indian Med J. 2015;64(2):76-80doi: 10.7727/wimj.2014.132.
Wang, Q. C., Cheng, W., Zhang, L., Sun, Y. X., & Xing, C. H. (2015). Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours. The West Indian medical journal, 64(2), 76-80. https://doi.org/10.7727/wimj.2014.132
Wang, Q C, et al. "Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours." The West Indian medical journal vol. 64,2 (2015): 76-80. doi: https://doi.org/10.7727/wimj.2014.132
Wang QC, Cheng W, Zhang L, Sun YX, Xing CH. Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours. West Indian Med J. 2015 Mar;64(2):76-80. doi: 10.7727/wimj.2014.132. Epub 2015 Jul 23. PMID: 26360677; PMCID: PMC4696636.
Copy Download .nbib Format: NLM
Share it on

West Indian Med J. 2015 Mar;64(2):76-80. doi: 10.7727/wimj.2014.132. Epub 2015 Jul 23.

Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours.

The West Indian medical journal

Q C Wang, W Cheng, L Zhang, Y X Sun, C H Xing

Affiliations

  1. Department of Ultrasound, Harbin Medical University Cancer Hospital, Heilongjiang province 150081, China.
  2. Department of Ultrasound, Harbin Medical University Cancer Hospital, Heilongjiang province 150081, China. [email protected].
  3. Department of Anesthesiology, Harbin Medical University Cancer Hospital, Heilongjiang province 150081, China.

PMID: 26360677 PMCID: PMC4696636 DOI: 10.7727/wimj.2014.132

Abstract

AIMS: Microwave ablation (MWA) is a technique which is used to destroy tumours and soft tissues by using microwave energy to create coagulation and localized tissue necrosis. It is used to treat the tumours which are considered to be inoperable and used to treat those patients who are ineligible for surgery due to some factors. The main objective of this study was to evaluate the use of MWA in the treatment of liver cancer.

METHODS: The data were collected from Department of Ultrasound, Harbin Medical University Cancer Hospital. From July 2010 to August 2011, a total of 123 patients with liver tumours was referred to Harbin Medical University Cancer Hospital. One hundred patients were selected for this study and treated with MWA. The study group contained 64 (64%) males and 36 (36%) females with an average age (± SD) of 52 (± 5.1) years.

RESULTS: One month after therapy, complete ablation was obtained in nodules. The complete ablation rate in tumors ≤ 3 cm and those > 3 cm was 98% and 94%, respectively. Microwave ablation success was higher with nodules ≤ 3 cm (57/58; 98.3%) in comparison to nodules > 3 cm.

CONCLUSION: Sonographically guided percutaneous microwave ablation proved to be safe, fast and effective for treatment of hepatocellular carcinoma.

References

  1. J Clin Gastroenterol. 2010 Apr;44(4):239-45 - PubMed
  2. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907 - PubMed
  3. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  4. Eur J Radiol. 2011 Aug;79(2):214-7 - PubMed
  5. Radiology. 2012 May;263(2):364-73 - PubMed
  6. Tumour Biol. 2012 Dec;33(6):1837-43 - PubMed
  7. Lancet. 2012 Nov 24;380(9856):1840-50 - PubMed
  8. Int J Cancer. 2013 Mar 1;132(5):1133-45 - PubMed
  9. Ann Surg. 2003 Feb;237(2):171-9 - PubMed
  10. Liver Int. 2003 Dec;23(6):405-9 - PubMed
  11. Radiology. 2006 Apr;239(1):94-102 - PubMed
  12. Clin Gastroenterol Hepatol. 2006 Jun;4(6):701-8 - PubMed
  13. Nat Rev Cancer. 2006 Sep;6(9):674-87 - PubMed
  14. Eur J Gastroenterol Hepatol. 2009 Jun;21(6):599-605 - PubMed

Publication Types